Sensory Neurons of the Dorsal Root Ganglia Become Hyperexcitable in a T-Cell-Mediated MOG-EAE Model of Multiple Sclerosis.


Journal

eNeuro
ISSN: 2373-2822
Titre abrégé: eNeuro
Pays: United States
ID NLM: 101647362

Informations de publication

Date de publication:
Historique:
received: 14 01 2019
revised: 26 02 2019
accepted: 11 03 2019
entrez: 9 4 2019
pubmed: 9 4 2019
medline: 7 3 2020
Statut: epublish

Résumé

Multiple sclerosis (MS) is an autoimmune, demyelinating disease of the central nervous system. Patients with MS typically present with visual, motor, and sensory deficits. However, an additional complication of MS in large subset of patients is neuropathic pain. To study the underlying immune-mediated pathophysiology of pain in MS we employed the myelin oligodendrocyte glycoprotein (MOG)-induced experimental autoimmune encephalitis (EAE) model in mice. Since sensory neurons are crucial for nociceptive transduction, we investigated the effect of this disease on sensory neurons of the lumbar dorsal root ganglia (DRG). Here, we report the disease was associated with activation of the complement system and the NLRP3 inflammasome in the DRG. We further observe a transient increase in the number of complement component 5a receptor 1-positive (C5aR1+) immune cells, CD4+ T-cells, and Iba1+ macrophages in the DRG. The absence of any significant change in the levels of mRNA for myelin proteins in the DRG and the sciatic nerve suggests that demyelination in the PNS is not a trigger for the immune response in the DRG. However, we did observe an induction of activating transcription factor 3 (ATF3) at disease onset and chronic disruption of cytoskeletal proteins in the DRG demonstrating neuronal injury in the PNS in response to the disease. Electrophysiological analysis revealed the emergence of hyperexcitability in medium-to-large (≥26 µm) diameter neurons, especially at the onset of MOG-EAE signs. These results provide conclusive evidence of immune activation, neuronal injury, and peripheral sensitization in MOG-EAE, a model classically considered to be centrally mediated.

Identifiants

pubmed: 30957012
doi: 10.1523/ENEURO.0024-19.2019
pii: eN-NWR-0024-19
pmc: PMC6449162
pii:
doi:

Substances chimiques

Myelin-Oligodendrocyte Glycoprotein 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

J Neurosci. 2017 Aug 2;37(31):7481-7499
pubmed: 28674170
J Neurosci. 2016 May 4;36(18):5055-70
pubmed: 27147658
J Neurol. 2013 Feb;260(2):351-67
pubmed: 22760942
Oncol Lett. 2018 Apr;15(4):5013-5019
pubmed: 29552137
Curr Top Behav Neurosci. 2014;20:201-15
pubmed: 24850077
J Neurosci. 2007 Aug 8;27(32):8699-708
pubmed: 17687047
Science. 2016 Jun 17;352(6292):aad1210
pubmed: 27313051
Pain. 2016 Apr;157(4):879-91
pubmed: 26785322
Science. 1965 Nov 19;150(3699):971-9
pubmed: 5320816
J Neurophysiol. 2001 Feb;85(2):630-43
pubmed: 11160499
Pharmacol Rev. 2018 Apr;70(2):315-347
pubmed: 29500312
J Neurol Sci. 1986 Oct;75(3):317-28
pubmed: 3490542
J Neurophysiol. 1997 Nov;78(5):2790-4
pubmed: 9356426
Immunol Rev. 2017 May;277(1):61-75
pubmed: 28462526
J Pain. 2009 Sep;10(9):895-926
pubmed: 19712899
J Allergy Clin Immunol. 2010 Feb;125(2 Suppl 2):S24-32
pubmed: 19932920
J Neurophysiol. 2012 Mar;107(6):1586-97
pubmed: 22170966
Pain. 2014 May;155(5):896-905
pubmed: 24447515
Front Cell Neurosci. 2014 Dec 17;8:429
pubmed: 25565963
Neurosci Lett. 2008 Apr 4;434(3):293-8
pubmed: 18314270
Neuropharmacology. 2017 Feb;113(Pt A):217-230
pubmed: 27743933
Mol Cell Neurosci. 2000 Feb;15(2):170-82
pubmed: 10673325
J Neuroinflammation. 2012 Oct 06;9:233
pubmed: 23039175
J Neurol Sci. 1986 Feb;72(2-3):231-42
pubmed: 3486944
Annu Rev Cell Dev Biol. 2014;30:503-33
pubmed: 25288117
Mol Neurobiol. 2018 May;55(5):4297-4310
pubmed: 28623618
Curr Opin Immunol. 2017 Dec;49:37-43
pubmed: 28926740
J Neurophysiol. 2001 Feb;85(2):644-58
pubmed: 11160500
J Neurophysiol. 1996 Sep;76(3):1924-41
pubmed: 8890304
J Comp Neurol. 2007 May 10;502(2):325-36
pubmed: 17348016
Sci Rep. 2017 Feb 09;7:42304
pubmed: 28181561
Cell. 2009 Oct 16;139(2):267-84
pubmed: 19837031
J Neuroimmune Pharmacol. 2013 Jun;8(3):677-90
pubmed: 23483352
Nat Med. 2015 Nov;21(11):1326-31
pubmed: 26479925
Nature. 1982 Apr 29;296(5860):860-2
pubmed: 7070525
J Neurophysiol. 2000 Apr;83(4):2179-91
pubmed: 10758127
J Neuroinflammation. 2010 Apr 16;7:27
pubmed: 20398373
Pain Med. 2015 Aug;16(8):1597-602
pubmed: 26087108
Pain. 2012 Feb;153(2):366-72
pubmed: 22137294
Pain. 2016 Mar;157(3):627-42
pubmed: 26545087
Mol Neurobiol. 2016 Nov;53(9):6540-6547
pubmed: 26614512
Lancet Neurol. 2015 Apr;14(4):406-19
pubmed: 25792099
J Neurosci. 2008 Dec 24;28(52):14062-73
pubmed: 19109489
J Neurophysiol. 1993 Apr;69(4):1071-81
pubmed: 8492149
J Chem Neuroanat. 2016 Oct;76(Pt A):9-18
pubmed: 27233660
Neurosci Lett. 2003 Oct 30;350(3):165-8
pubmed: 14550920
Neuroscience. 2017 Mar 6;344:178-186
pubmed: 28057537
Mult Scler. 2009 Oct;15(10):1135-45
pubmed: 19667008
Nat Neurosci. 2015 Jan;18(1):145-53
pubmed: 25420068
Front Immunol. 2016 Sep 22;7:369
pubmed: 27713744
Front Mol Neurosci. 2012 Feb 14;5:7
pubmed: 22347845
Curr Opin Neurobiol. 2016 Feb;36:31-7
pubmed: 26363576
Clin J Am Soc Nephrol. 2015 Sep 4;10(9):1636-50
pubmed: 25568220
Mt Sinai J Med. 2011 Mar-Apr;78(2):231-43
pubmed: 21425267
J Neurophysiol. 2003 Mar;89(3):1588-602
pubmed: 12612024
J Physiol. 2015 Aug 15;593(16):3739-55
pubmed: 26110238
Pain. 2010 Feb;148(2):343-52
pubmed: 20031321
Exp Neurol. 2015 Sep;271:279-90
pubmed: 26033473
Exp Neurol. 2016 Sep;283(Pt A):224-34
pubmed: 27343802
Ann Neurol. 2013 Nov;74(5):630-6
pubmed: 24018757

Auteurs

Muhammad Saad Yousuf (MS)

Neuroscience and Mental Health Institute, University of Alberta, Edmonton, Alberta T6G 2E1, Canada.

Myung-Chul Noh (MC)

Department of Pharmacology, University of Alberta, Edmonton, Alberta T6E 2H7, Canada.

Timothy N Friedman (TN)

Neuroscience and Mental Health Institute, University of Alberta, Edmonton, Alberta T6G 2E1, Canada.

Kasia Zubkow (K)

Neuroscience and Mental Health Institute, University of Alberta, Edmonton, Alberta T6G 2E1, Canada.

John Christy Johnson (JC)

Neuroscience and Mental Health Institute, University of Alberta, Edmonton, Alberta T6G 2E1, Canada.

Gustavo Tenorio (G)

Department of Anesthesiology and Pain Medicine, University of Alberta, Edmonton, Alberta T6G 2G3, Canada.

Harley T Kurata (HT)

Neuroscience and Mental Health Institute, University of Alberta, Edmonton, Alberta T6G 2E1, Canada.
Department of Pharmacology, University of Alberta, Edmonton, Alberta T6E 2H7, Canada.

Peter A Smith (PA)

Neuroscience and Mental Health Institute, University of Alberta, Edmonton, Alberta T6G 2E1, Canada.
Department of Pharmacology, University of Alberta, Edmonton, Alberta T6E 2H7, Canada.

Bradley J Kerr (BJ)

Neuroscience and Mental Health Institute, University of Alberta, Edmonton, Alberta T6G 2E1, Canada.
Department of Pharmacology, University of Alberta, Edmonton, Alberta T6E 2H7, Canada.
Department of Anesthesiology and Pain Medicine, University of Alberta, Edmonton, Alberta T6G 2G3, Canada.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH